GovChime
AWARDBPA CALLOther than small business

BPA call 75F40123F19006DELOITTE CONSULTING LLP

Overview

Award facts

Net obligations
$24.33M
$24,329,855of $25.70M potential value
Outlays (paid to date)
$12.48M
$12.48M paid of $24.33M obligated$12,476,759
Period of performance
Dec 8, 2022 to Sep 28, 2027
Ends in 10 months
Modifications
17
Latest action Sep 24, 2026
Contract type
BPA call
PIID 75F40123F19006

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

FDA BUDGET EXECUTION AND CONTROL SUPPORT

Dates and value

Award date
Signed on Dec 8, 2022
Current value
$25,207,267Base and exercised options
Potential value (if all options are exercised)
$25,701,177
Parent contract vehicle
75F40121A00003 (BPA, single award) — 12 orders recorded under it

Obligations by fiscal year of action

  • FY2026: $11,432,814
  • FY2025: $7,245,284
  • FY2024: $2,808,520
  • FY2023: $2,843,237

Total across 4 fiscal years: $24,329,855

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 24, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationARLINGTON, VA
UEICKV2L9GZKJK3
CAGE code1TTG5
Business sizeOther than small businessSize at award, per the contracting officer
Organization typePartnership

Business types and certifications

For-profit organizationPartnership or LLP

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded from
Foods; Human drugs; Devices and radiological health; National center for toxicological research; Fda other activities (fda headquaters); Animal drugs and feed; Biologics; Fda user fees (non general fund); Fda working capital fundProgram activities075-0600, 075-4613Federal accounts (agency financial reports)

Place of performance

Place of performance
Beltsville, Prince Georges County, Maryland 20705-3106
Congressional district (place of performance)
MD-04As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Subject to multiple award fair opportunityMAFO
Set-aside
Not reported
Contract pricing
Labor hoursZ

Solicitation and notices

Solicitation ID
75F40122Q00129(as reported)
Solicitation date
Aug 24, 2022

Contract details

Service Contract Act labor standards
No
Government-furnished property
Transaction uses GFE/GFPY
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Dec 8, 2022Base obligation at award: $1,796,447
Latest action
Sep 24, 2026 — Funding onlyModification P00017; obligation change +$3,826,333; funding only: changes obligations, not scope
Latest substantive action
Apr 29, 2025 — Terminated for convenienceModification P00008; obligation change -$370,723
Latest funding action
Sep 24, 2026 — Funding onlyModification P00017; obligation change +$3,826,333; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Funding only7
  • Other administrative action7
  • Option exercised2
  • Terminated for convenience1
18 actions recorded, Dec 8, 2022 to Sep 24, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
$3,826,333
Latest action: change in base and all options
$3,826,333

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
BPA callA
Parent vehicle type
BPAE
Parent vehicle: multiple or single award
Single awardS
Parent vehicle agency
Food And Drug Administration7524
Awarding agency code
7500
Awarding sub-tier code
7524
Contracting office code
75F401
Transactions recorded under this award key
18

Funding

Funding agency code
7500
Funding sub-tier code
7524
Funding office code
75F401
Treasury accounts
  • 075-2023/2023-0600-000
  • 075-2025/2025-0600-000
  • 075-X-0600-000
  • 075-X-4613-000
Object classes
  • 25.1: Advisory and assistance services
  • 25.2: Other services from non-Federal sources
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression